In this analysis of LUCENT-1 data, the univariable analysis identified left-sided colitis/proctitis, lower fCal level, lower CRP level, baseline MMS, lower ES, lower SF subscore, and no prior biologic or tofacitinib failure as candidate prognostic factors for patients achieving DC at W12. This evidence concerns the gene CRP and proctitis.